HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

HIV | Image credit: Corona Borealis - stock.adobe.com
New Data Provide Clearer Picture on Adherence to Lenacapavir

November 18th 2024

An update from the PURPOSE 2 trial focused on adherence and pharmacokinetics data for lenacapavir, used to prevent HIV.

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
BIC/FTC/TAF Effective at Virologic Suppression in HIV Presenting Late

November 15th 2024

Liver | Image credit: PIC4U - stock.adobe.com
Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV

November 12th 2024

Madalitso Juwayeyi
Empowering Young Women in the Fight Against HIV

November 8th 2024

HIV/AIDS | Image credit: SpeedShutter - stock.adobe.com
Controlling Spread of Drug-Resistant HIV May Necessitate Interventions

November 4th 2024

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
November 21st 2024

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Will Nutland, DrPH, cofounder of PrEPster
July 1st 2022

Dr Will Nutland Discusses Enhanced Outreach to Queer Migrant Men Living With HIV in London

Maggie L. Shaw
Will Nutland, DrPH, is cofounder of PrEPster, honorary assistant professor at the London School of Hygiene and Tropical Medicine, and an activist.
Image of a red AIDS ribbon
June 28th 2022

Risk for CVD Increases Following INSTI Use for HIV

Maggie L. Shaw
A possible connection between integrase strand-transfer inhibitor (INSTI) use for HIV and cardiovascular disease (CVD) was investigated in this new study from an international team wanting more knowledge on the drug class’s treatment effects.
What We’re Reading: Bipartisan Gun Law Passes Senate; HIV Cases Dropped During Pandemic; COVID-19 Vaccines Save 20 Million Lives
June 24th 2022

What We’re Reading: Bipartisan Gun Law Passes Senate; HIV Cases Dropped During Pandemic; COVID-19 Vaccines Save 20 Million Lives

AJMC Staff
The Senate passed a bipartisan gun law, the first major gun legislation in nearly 30 years, which now goes to the House; HIV cases dropped during the pandemic, perhaps due to lack of testing; researchers say COVID-19 vaccines have saved nearly 20 million lives but could be even more effective.
Image of a vaccine
June 23rd 2022

Meningococcal Vaccine Uptake Lagging Among People Living With HIV

Maggie L. Shaw
The findings of this study, which used insurance claims data for patients 2 years and older to determine rates of meningococcal A, C, W, Y vaccine uptake, points to the need for more education, the authors said.
Patrick Morley, Bruce House office and communications coordinator
June 20th 2022

Canada’s Bruce House: U=U Is Fundamental to What We Do

Maggie L. Shaw
Bruce House in Ottawa, Ontario, Canada, has been serving individuals living with HIV and AIDS for 34-plus years. Here we speak with Patrick Morley, office and communications coordinator.
Image of scientific research
June 18th 2022

Emerging Nonepidemic Kaposi Sarcoma Subtype Shows Favorable Outcomes According to Study

Lindsey Mulrooney
Researchers emphasize the importance of characterizing and recognizing this subtype to identify patients at risk of Kaposi sarcoma.
Image of persons living with HIV
June 15th 2022

Anal Cancer Risk in PLWH Halved Following Precancerous Lesion Treatment

Maggie L. Shaw
The new trial was the first to investigate outcomes among a patient population living with HIV (PLWH) who were treated for anal precancerous growths, or high-grade squamous intraepithelial lesions.
Amanda Ely, CEO, Children’s HIV Association
June 11th 2022

CHIVA’s Amanda Ely Addresses Difficulties Involved With Telling Children They Have HIV

Maggie L. Shaw
Amanda Ely is CEO of the Children’s HIV Association (CHIVA), an organization that provides support to children living with HIV in the United Kingdom and Ireland and their families.
What We're Reading
June 9th 2022

What We’re Reading: Rectal Cancer Drug Results Released; Military HIV Policies Updated; Executive Order on Abortion Rights

AJMC Staff
An experimental cancer drug made 100% of patients’ rectal tumors disappear in a small study; US military members with HIV with an undetectable viral load and no symptoms will no longer face restrictions in deployment or commission; President Biden may sign an executive order on abortion rights depending on the Supreme Court’s ruling.
HIV
June 3rd 2022

Anti-HIV Antibody Combination Leads to Long-term HIV Suppression, Researchers Find

Hayden E. Klein
A small study found that 2 broadly neutralizing anti-HIV antibodies could help achieve long-term virological suppression in patients with HIV who were taken off antiretroviral therapy.
Will Nutland, DrPH, cofounder of PrEPster
May 31st 2022

Dr Will Nutland Discusses High-risk Groups in the UK Needing PrEP

Maggie L. Shaw
Will Nutland, DrPH, is cofounder of PrEPster, honorary assistant professor at the London School of Hygiene and Tropical Medicine, and an activist.
HIV cells
May 27th 2022

Study Finds Potential Cancer Risk Biomarker in People Living With HIV

Hayden E. Klein
Using a 6-month lagged CD4/CD8 ratio, researchers found a ratio of 0.30 was associated with a 24% increased risk of any incident cancer among people living with HIV, compared with a ratio of 0.80.
woman holding red HIV ribbon
May 19th 2022

DREAMS HIV Interventions Linked to Favorable Behavioral Outcomes Among Young Women in South Africa

Hayden E. Klein
Adolescent girls and young women in South Africa were more likely to practice favorable sexual behaviors if they accessed DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe)–like interventions such as school-based HIV prevention and HIV testing.
Anna Brewster, services and volunteer manager, The Food Chain
May 16th 2022

The UK’s The Food Chain Fosters Food Engagement for PLWH Through Cooking

Maggie L. Shaw
Anna Brewster, services and volunteer manager at The Food Chain, a London-based charity that provides short-term assistance to persons living with HIV (PLWH), discusses how education provided through the Eating Positively program connects the importance of food and proper nutrition to health outcomes.
mother and baby daughter
May 14th 2022

Long-term ART Safe, Effective, Maintainable in Mothers With HIV

Hayden E. Klein
Research shows that long-term antiretroviral therapy (ART) can improve the overall health and survival of mothers living with HIV and their children who have been exposed to HIV.
Anna Marzec-Bogusławska, MD, MPH, managing director, National AIDS Center, Poland
May 9th 2022

Dr Anna Marzec-Bogusławska: Advocacy Helped to Overcome Fear, Stigma of HIV/AIDS in Poland

Maggie L. Shaw
Anna Marzec-Bogusławska, MD, MPH, managing director, National AIDS Center, Warsaw, Poland, discusses how stigma and discrimination permeated the beginning of the HIV/AIDS epidemic the country in the early 1980s and ways that advocates stepped up to overcome peoples’ fears.
woman with red hair
May 5th 2022

Cortisol, Cortisone Levels in Hair May Be Indicators of HIV Disease Progression, Study Finds

Hayden E. Klein
New research shows that cortisol and cortisone levels in the hair of people living with HIV were negatively associated with CD4 count, but not with HIV viral load.
Nicoleta Dascalu, founding member and advocacy manager, ARAS
May 3rd 2022

PLWH in Romania Need More Comprehensive Care, Advocate Says

Maggie L. Shaw
Nicoleta Dascalu, founding member and advocacy manager of Asociaţia Română Anti-SIDA (ARAS; Romanian Association Against AIDS), discusses the status of care for persons living with HIV/AIDS (PLWH) in Romania, including health care coverage and lack of adequate medication access.
Jason Myers, PhD, CEO, New Zealand AIDS Foundation
April 29th 2022

Dr Jason Myers Discusses How New Zealand Pivoted to Continue HIV Care During the Pandemic

Maggie L. Shaw
Jason Myers, PhD, CEO of the New Zealand AIDS Foundation, addresses how New Zealand promptly adjusted its delivery of services for people living with HIV and AIDS in New Zealand, with examples including HIV self-test kits, online counseling, and provision of mental health care assistance.
kidney graphic
April 27th 2022

TDF-Based PrEP Associated With Increased Risk of Kidney Adverse Events, Review Finds

Hayden E. Klein
According to a review, few individuals initiating tenofovir disoproxil fumarate (TDF)–based HIV pre-exposure prophylaxis (PrEP) experienced clinically significant kidney impairment, although the risk was increased.
Blood samples
April 20th 2022

Review Finds POC VL Testing Has High Specificity for HIV Viral Load

Julia Bonavitacola
Researchers found point-of-care viral load (POC VL) tests have high sensitivity and specificity for detection of viral loads of at least 1000 copies/mL.
Emergency room sign
April 17th 2022

Research Shows Extremely Low HIV Testing Performed at EDs in 2018

Hayden E. Klein
Research shows that only 1.05% of US emergency department (ED) visits included HIV testing in 2018 and that HIV testing rates varied by race, age group, and region.
Improving Diversity in Clinical Trials: How Early-Stage Investigators Are Reaching Underserved Populations
April 13th 2022

Improving Diversity in Clinical Trials: How Early-Stage Investigators Are Reaching Underserved Populations

Matthew Gavidia
Editor’s Note: After this issue of Evidence-Based Oncology™ went to press, Bristol Myers Squibb Foundation announced the $100 million, 5-year initiative will now be called the Robert A. Winn Diversity in Clinical Trials Award Program. The program will also receive a $14 million donation from Gilead Sciences, Inc., over the next 4 years.
Image of individuals of various races
April 13th 2022

Lifetime HIV Risk Disparities Persist, According to CDC Data

Maggie L. Shaw
Using data from the National HIV Surveillance System, the National Center for Health Statistics, and the US Census, a team from the CDC investigated lifetime HIV risk in the United States.
Mother holding baby
April 6th 2022

Protease Inhibitor–Based ART Associated With Babies Born Small or Very Small

Hayden E. Klein
A large systematic review on pregnant women living with HIV found that protease inhibitor–based antiretroviral therapy (ART) use was associated with increased risk of babies being born small or very small for their gestational age, but not with other adverse pregnancy outcomes.
Image of a pill bursting with money
April 4th 2022

Medicare Must Address High ART Costs, Investigators Argue

Maggie L. Shaw
With more people living with HIV now reaching advanced ages and qualifying for Medicare coverage, this new study investigated HIV-related influences on their health care spending, particularly antiretroviral therapy (ART), compared with a population who does not have HIV.
Group of teens
April 2nd 2022

Comprehensive Sexuality Education Linked to Lower Rates of HIV, Pregnancy Among Adolescent Girls

Hayden E. Klein
Attending comprehensive sexuality education (CSE) was associated with increased access to HIV testing among adolescent girls, regardless of whether they were actively in school.
Jorge Plutzky, MD
March 30th 2022

Dr Jorge Plutzky Explains How Traditional CV Risk Prediction Models Fall Short for Patients With HIV

Traditional cardiovascular (CV) risk prediction models may not apply accurately to patients with HIV who may develop the cardiovascular disease younger than usual, said Jorge Plutzky, MD, director of the Vascular Disease Prevention Program and director of Preventive Cardiology at Brigham and Women’s Hospital and associate professor of medicine at Harvard Medical School.
person taking blood pressure
March 26th 2022

People With HIV More Likely to Develop Hypertension After Starting INSTI-Based ART vs NNRTI

Hayden E. Klein
Adults living with HIV receiving integrase strand transfer inhibitor (INSTI)–based antiretroviral therapy (ART) had a 76% higher incidence of hypertension compared with adults receiving non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Jorge Plutzky, MD
March 25th 2022

Dr Jorge Plutzky: Evidence Points to Patients With HIV Having an Increased Risk of Cardiovascular Disease

There is evidence that people with HIV may have increased risk of cardiovascular disease and researchers are still trying to understand why, said Jorge Plutzky, MD, director of the Vascular Disease Prevention Program and director of Preventive Cardiology at Brigham and Women’s Hospital and associate professor of medicine at Harvard Medical School.
<1
...
456789101112
...
30>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo